240 related articles for article (PubMed ID: 22927971)
1. Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapies.
Preukschas M; Hagel C; Schulte A; Weber K; Lamszus K; Sievert H; Pällmann N; Bokemeyer C; Hauber J; Braig M; Balabanov S
PLoS One; 2012; 7(8):e43468. PubMed ID: 22927971
[TBL] [Abstract][Full Text] [Related]
2. Synergistic drug combination GC7/DFMO suppresses hypusine/spermidine-dependent eIF5A activation and induces apoptotic cell death in neuroblastoma.
Schultz CR; Geerts D; Mooney M; El-Khawaja R; Koster J; Bachmann AS
Biochem J; 2018 Jan; 475(2):531-545. PubMed ID: 29295892
[TBL] [Abstract][Full Text] [Related]
3. Production of active recombinant eIF5A: reconstitution in E.coli of eukaryotic hypusine modification of eIF5A by its coexpression with modifying enzymes.
Park JH; Dias CA; Lee SB; Valentini SR; Sokabe M; Fraser CS; Park MH
Protein Eng Des Sel; 2011 Mar; 24(3):301-9. PubMed ID: 21131325
[TBL] [Abstract][Full Text] [Related]
4. Biological Relevance and Therapeutic Potential of the Hypusine Modification System.
Pällmann N; Braig M; Sievert H; Preukschas M; Hermans-Borgmeyer I; Schweizer M; Nagel CH; Neumann M; Wild P; Haralambieva E; Hagel C; Bokemeyer C; Hauber J; Balabanov S
J Biol Chem; 2015 Jul; 290(30):18343-60. PubMed ID: 26037925
[TBL] [Abstract][Full Text] [Related]
5. Posttranslational synthesis of hypusine: evolutionary progression and specificity of the hypusine modification.
Wolff EC; Kang KR; Kim YS; Park MH
Amino Acids; 2007 Aug; 33(2):341-50. PubMed ID: 17476569
[TBL] [Abstract][Full Text] [Related]
6. Effects of N1-guanyl-1,7-diaminoheptane, an inhibitor of deoxyhypusine synthase, on the growth of tumorigenic cell lines in culture.
Shi XP; Yin KC; Ahern J; Davis LJ; Stern AM; Waxman L
Biochim Biophys Acta; 1996 Jan; 1310(1):119-26. PubMed ID: 9244184
[TBL] [Abstract][Full Text] [Related]
7. Marked elevation of hypusine formation activity on eukaryotic initiation factor 5A in v-HA-RAS transformed mouse NIH3T3 cells.
Chen ZP; Chen KY
Cancer Lett; 1997 May; 115(2):235-41. PubMed ID: 9149130
[TBL] [Abstract][Full Text] [Related]
8. Dramatic attenuation of hypusine formation on eukaryotic initiation factor 5A during senescence of IMR-90 human diploid fibroblasts.
Chen ZP; Chen KY
J Cell Physiol; 1997 Mar; 170(3):248-54. PubMed ID: 9066781
[TBL] [Abstract][Full Text] [Related]
9. Protein-protein-interaction network organization of the hypusine modification system.
Sievert H; Venz S; Platas-Barradas O; Dhople VM; Schaletzky M; Nagel CH; Braig M; Preukschas M; Pällmann N; Bokemeyer C; Brümmendorf TH; Pörtner R; Walther R; Duncan KE; Hauber J; Balabanov S
Mol Cell Proteomics; 2012 Nov; 11(11):1289-305. PubMed ID: 22888148
[TBL] [Abstract][Full Text] [Related]
10. Hypusine Signaling Promotes Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
Lemay SE; Grobs Y; Romanet C; Martineau S; Salem M; Shimauchi T; Breuils-Bonnet S; Bourgeois A; Théberge C; Pelletier A; Potus F; Provencher S; Bonnet S; Boucherat O
Am J Respir Crit Care Med; 2024 Jun; 209(11):1376-1391. PubMed ID: 38261723
[No Abstract] [Full Text] [Related]
11. Hypusine: its post-translational formation in eukaryotic initiation factor 5A and its potential role in cellular regulation.
Park MH; Wolff EC; Folk JE
Biofactors; 1993 May; 4(2):95-104. PubMed ID: 8347280
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo silencing of plasmodial dhs and eIf-5a genes in a putative, non-canonical RNAi-related pathway.
Schwentke A; Krepstakies M; Mueller AK; Hammerschmidt-Kamper C; Motaal BA; Bernhard T; Hauber J; Kaiser A
BMC Microbiol; 2012 Jun; 12():107. PubMed ID: 22694849
[TBL] [Abstract][Full Text] [Related]
13. Isolation and characterization of senescence-induced cDNAs encoding deoxyhypusine synthase and eucaryotic translation initiation factor 5A from tomato.
Wang TW; Lu L; Wang D; Thompson JE
J Biol Chem; 2001 May; 276(20):17541-9. PubMed ID: 11278418
[TBL] [Abstract][Full Text] [Related]
14. Effect of N1-guanyl-1,7-diaminoheptane, an inhibitor of deoxyhypusine synthase, on endothelial cell growth, differentiation and apoptosis.
Lee Y; Kim HK; Park HE; Park MH; Joe YA
Mol Cell Biochem; 2002 Aug; 237(1-2):69-76. PubMed ID: 12236588
[TBL] [Abstract][Full Text] [Related]
15. Modification of eukaryotic initiation factor 5A from Plasmodium vivax by a truncated deoxyhypusine synthase from Plasmodium falciparum: An enzyme with dual enzymatic properties.
Kaiser A; Hammels I; Gottwald A; Nassar M; Zaghloul MS; Motaal BA; Hauber J; Hoerauf A
Bioorg Med Chem; 2007 Sep; 15(18):6200-7. PubMed ID: 17591443
[TBL] [Abstract][Full Text] [Related]
16. The eukaryotic initiation factor 5A is involved in the regulation of proliferation and apoptosis induced by interferon-alpha and EGF in human cancer cells.
Caraglia M; Marra M; Giuberti G; D'Alessandro AM; Baldi A; Tassone P; Venuta S; Tagliaferri P; Abbruzzese A
J Biochem; 2003 Jun; 133(6):757-65. PubMed ID: 12869532
[TBL] [Abstract][Full Text] [Related]
17. Is hypusine essential for eukaryotic cell proliferation?
Park MH; Wolff EC; Folk JE
Trends Biochem Sci; 1993 Dec; 18(12):475-9. PubMed ID: 8108861
[TBL] [Abstract][Full Text] [Related]
18. The post-translational synthesis of a polyamine-derived amino acid, hypusine, in the eukaryotic translation initiation factor 5A (eIF5A).
Park MH
J Biochem; 2006 Feb; 139(2):161-9. PubMed ID: 16452303
[TBL] [Abstract][Full Text] [Related]
19. Structural features of the eIF-5A precursor required for posttranslational synthesis of deoxyhypusine.
Joe YA; Park MH
J Biol Chem; 1994 Oct; 269(41):25916-21. PubMed ID: 7929297
[TBL] [Abstract][Full Text] [Related]
20. Interaction of eukaryotic initiation factor 5A with the human immunodeficiency virus type 1 Rev response element RNA and U6 snRNA requires deoxyhypusine or hypusine modification.
Liu YP; Nemeroff M; Yan YP; Chen KY
Biol Signals; 1997; 6(3):166-74. PubMed ID: 9285100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
